Activation and activators of TRPV1 and their pharmaceutical implication

Current Pharmaceutical Design

Volumn 11, Issue 21, 2005, Pages 2687-2698

  Suh, Young Ger ^a   Oh, Uhtaek ^a  

^a Seoul National University   (South Korea)

Author keywords

12 HPETE; Analgesia; Antagonist; Lipoxygenase; Pain; SC0030; TRPV1; Vanilloid receptor 1

Indexed keywords

ANANDAMIDE; BRADYKININ; CALCIUM ION; CAPSAICIN; CAPSAZEPINE; CATION CHANNEL; CYCLIC AMP DEPENDENT PROTEIN KINASE; HISTAMINE; ICOSATETRAENOIC ACID; INDOMETACIN; LIPOXYGENASE; MEPACRINE; NORDIHYDROGUAIARETIC ACID; PHOSPHOLIPASE C; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C; RECEPTOR BLOCKING AGENT; RESINIFERATOXIN; SC 0030; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

AMINO ACID SEQUENCE; ANALGESIC ACTIVITY; ANTINOCICEPTION; BINDING AFFINITY; BINDING SITE; BODY TEMPERATURE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CHANNEL GATING; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME PHOSPHORYLATION; HUMAN; HYPERALGESIA; HYPOTHERMIA; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS;

ANALGESICS; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; HUMANS; ION CHANNELS; LEUKOTRIENES; MODELS, MOLECULAR; NEURONS, AFFERENT; PAIN; PHOSPHORYLATION; TRPV CATION CHANNELS;

EID: 22944473968     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612054546789     Document Type: Review

References (103)

1. Simone DA, Baumann TK, Lamotte RH. Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin. Pain 1989; 38: 99-107.
2. Simone DA, Ngeow JYF, Putterman GJ, Lamotte RH. Hyperalgesia to heat after intradermal injection of capsaicin. Brain Res 1987; 418: 201-3.
3. Szolcsanyi J, Jancso-Gabor A. Sensory effects of capsaicin congeners. I. Relationship between chemical structure and pain producing potency of pungent agents. Drug Res 1975; 25: 1877-81.
4. Szolcsanyi J. A pharmacological approach to elucidation of the role of different nerve fibres and receptor endings in mediation of pain. J Physiol (Paris) 1977; 73: 251-9.
5. Szolcsanyi J. Actions of capsaicin on sensory receptors. In: Wood J, editor. Capsaicin in the study of pain. London: Academic Press; 1993. p. 1-26.
6. Wood JN, Winter J, James IF, Rang HP, Yeats J, Bevan S. Capsaicin-induced ion fluxes in dorsal root ganglion cells in culture. J Neurosci 1988; 8: 3208-20.
7. Bevan S, Szolcsanyi J. Sensory neuron-specific actions of capsaicin: mechanisms and applications. Trends Pharmacol Sci 1990; 11: 330-3.
8. Liu L, Simon SA. A rapid capsaicin-activated current in rat trigeminal ganglion neurons. Proc Natl Acad Sci USA 1994; 91: 738-41.
9. Oh U, Hwang SW, Kim D. Capsaicin activates a nonselective cation channel in cultured neonatal rat dorsal root ganglion neurons. J Neurosci 1996: 16: 1659-67.
10. Hille B. Ionic Channels of Excitable Membranes. Sunderland, MA: Sinauer; 2001.
11. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389: 816-24.
12. Montell C, Birnbaumer L, Flockerzi V. The TRP channels, a remarkably functional family. Cell 2002; 108: 595-8.
13. Montell C, Birnbaumer L, Flockerzi V, Bindels RJ, Bruford EA. Caterina MJ, et al. A unified nomenclature for the superfamily of TRP cation channels. Mol Cell 2002; 9: 229-31.
14. Clapham DE. TRP channels as cellular sensors. Nature 2003; 426: 517-24.
15. Shin JS, Wang MH, Hwang SW, Cho H, Cho SY, Kwon MJ, et al. Differences in sensitivity of vanilloid receptor 1 transfected to human embryonic kidney cells and capsaicin-activated channels in cultured rat dorsal root ganglion neurons to capsaicin receptor agonists. Neurosci Lett 2001; 299: 135-9.
16. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998; 21: 531-43.
17. Mezey E, Toth ZE, Cortright DN, Arzubi MK, Krause JE, Elde R, et al. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA 2000; 97: 3655-60.
18. Sanchez JF, Krause JE, Cortright DN. The distribution and regulation of vanilloid receptor VR1 and VR1 5′ splice variant RNA expression in rat. Neuroscience 2001; 107: 373-81.
19. Birder LA, Kanai AJ, de Groat WC, Kiss S, Nealen ML, Burke NE, et al. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci USA 2001; 98: 13396-401.
20. Birder LA, Nakamura Y, Kiss S, Nealen ML, Barrick S, Kanai AJ, et al. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci 2002; 5: 856-60.
21. Avelino A, Cruz C, Nagy I, Cruz P. Vanilloid receptor 1 expression in the rat urinarv tract. Neuroscience 2002; 109: 787-98.
22. Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 2001; 24: 487-517.
23. Kedei N, Szabo T, Lile JD, Treanor JJ, Olah Z, Iadarola MJ, et al. Analysis of the native quaternary structure of vanilloid receptor 1. J Biol Chem 2001; 276: 28613-9.
24. Peier AM, Reeve AJ, Andersson DA, Moqrich A, Earley TJ, Hergarden AC, et al. A heat-sensitive TRP channel expressed in keratinocytes. Science 2002; 296: 2046-9.
25. Smith GD, Gunthorpe MJ, Kelsell RE, Hayes PD, Reilly P, Facer P, et al. TRPV3 is a temperature-sensitive vanilloid receptor-like protein. Nature 2002; 418: 186-90.
26. Xu H, Ramsey IS, Kotecha SA, Moran MM, Chong JA, Lawson D, et al. TRPV3 is a calcium-permeable temperature-sensitive cation channel. Nature 2002; 418: 181-6.
27. Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, et al. Impaired nociception and pain sensation in mice lacking tlae capsaicin receptor. Science 2000; 288: 306-13.
28. Davis JB, Gray J, Gunthorpe MJ, Hatcher JP, Davey PT, Overend P, et al. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 2000; 405: 183-7.
29. Cesare P, Moriondo A, Vellani V, McNaughton PA. Ion channels gated by heat. Proc Natl Acad Sci USA 1999; 96: 7658-63.
30. Cesare P, Dekker LV, Sardini A, Parker PJ, McNaughton PA. Specific involvement of PKC-epsilon in sensitization of the neuronal response to painful heat. Neuron 1999; 23: 617-24.
31. Premkumar LS, Ahern GP. Induction of vanilloid receptor channel activity by protein kinase C. Nature 2000; 408: 985-90.
32. Vellani V, Mapplebeck S, Moriondo A, Davis JB, McNaughton PA. Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J Physiol 2001; 534: 813-25.
33. Numazaki M, Tominaga T, Toyooka H, Tominaga M. Direct phosphorylation of capsaicin receptor VR1 by protein kinase Cepsilon and identification of two target serine residues. J Biol Chem 2002; 277: 13375-8.
34. Tominaga M, Wada M, Masu M. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci USA 2001; 98: 6951-6.
35. Sugiura T, Tominaga M, Katsuya H, Mizumura K. Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1. J Neurophysiol 2002; 88: 544-8.
36. Taiwo YO, Levine JD. Effects of cyclooxygenase products of arachidonic acid metabolism on cutaneous nociceptive threshold in the rat. Brain Res 1990; 537: 372-4.
37. Taiwo YO, Bjerknes LK, Goetzl EJ, Levine JD. Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Neuroscience 1989; 32: 577-80.
38. Rathee PK, Distler C, Obreja O, Neuhuber W, Wang GK, Wang SY, et al. PKA/AKAP/VR-1 module: A common link of Gs-mediated signaling to thermal hyperalgesia. J Neurosci 2002; 22: 4740-5.
39. Bhave G, Zhu W, Wang H, Brasier DJ, Oxford GS, Gereau RW 4th. cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron 2002; 35: 721-31.
40. Chuang HH, Prescott ED, Kong H, Shields S, Jordt SE, Basbaum AI, et al. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4, 5)P2-mediated inhibition. Nature 2001; 411: 957-62.
41. Prescott ED, Julius D. A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity. Science 2003; 300: 1284-8.
42. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991; 43: 143-201.
43. Cholewinski A, Burgess GM, Bevan S. The role of calcium in capsaicin-induced desensitization in rat cultured dorsal root ganglion neurons. Neuroscience 1993; 55: 1015-23.
44. Winter J, Dray A, Wood JN, Yeats JC, Bevan S. Cellular mechanism of action of resiniferatoxin: a potent sensory neuron excitotoxin. Brain Res 1990; 520: 131-40.
45. Szolcsanyi J, Jancso-Labor A. Sensory effects of capsaicin congeners II. Importance of chemical structure and pungency in desensitizing activity of capsaicin-type compounds. Drug Res 1976; 26: 33-7.
46. Szolcsanyi J. Selective responsiveness of polymodal nociceptors of rabbit ear to capsaicin, bradykinin and ultra-violet irradiation. J Physiol (Lond) 1987; 388: 9-23.
47. Maggi CA, Patacchini R, Santicioli P, Guiliani S, Geppetti P, Meli A. Protective action of ruthenium red toward capsaicin desensitization of sensory fibers. Neurosci Lett 1988; 88: 201-5.
48. Dray A, Bettaney J, Forster P. Capsaicin desensitization of peripheral nociceptive fibers does not impair sensitivity to other noxious stimuli. Neurosci Lett 1989; 99: 50-4.
49. Docherty RJ, Yeats JC, Bevan S, Boddeke HW. Inhibition of calcineurin inhibits the desensitization of capsaicin-evoked currents in cultured dorsal root ganglion neurones from adult rats. Pflugers Arch 1996; 431: 828-37.
50. Liu L, Simon SA. Capsaicin-induced currents with distinct desensitization and Ca2+ dependence in rat trigeminal ganglion cells. J Neurophysiol 1996; 75: 1503-14.
51. Dray A. Mechanism of action of capsaicin-like molecules on sensory neurons. Life Sci 1992; 51: 1759-65.
52. Dray A. Neuropharmacological mechanisms of capsaicin and related substances. Biochem Pharmacol 1992; 44: 611-5.
53. Jung J, Shin JS. Lee S-Y, Hwang SW, Koo J, Cho H, et al. Phosphorylation of vanilloid receptor 1 by Ca2+/calmodulin-dependent kinases II regulates its vanilloid binding. J Biol Chem 2004; 279: 7048-54.
54. Numazaki M, Tominaga T, Takeuchi K, Murayama N, Toyooka H, Tominaga M. Structural determinant of TRPV1 desensitization interacts with calmodulin. Proc Natl Acad Sci USA 2003; 100: 8002-6.
55. Jung J, Hwang SW, Kwak J, Lee SY, Kang CJ, Kim WB, et al. Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J Neurosci 1999; 19: 529-38.
56. Jung J, Lee S-Y, Hwang SW, Cho H, Shin J, Kang Y-S, et al. Agonist recognition sites in the cytosolic tails of vanilloid receptor 1. J Biol Chem 2002; 277: 44448-54.
57. Jordt SE, Julius D. Molecular basis for species-specific sensitivity to "hot" chili peppers. Cell 2002; 108: 421-30.
58. Walpole CSJ, Wrigglesworth R. Structural requirements for capsaicin agonists and antagonists. In: Wood J, editor. Capsaicin in the Study of Pain. London: Academic Press 1993: p. 63-81.
59. Kwak JY, Jung JY, Hwang SW, Lee WT, Oh U. A capsaicin-receptor antagonist, capsazepine, reduces inflammation-induced hyperalgesic responses in the rat: evidence for an endogenous capsaicin-like substance. Neuroscience 1998; 86: 619-26.
60. Bevan S, Hothi S, Hughes G, James IF, Rang HP, Shah K, et al. Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. Br J Pharmacol 1992; 107: 544-52.
61. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999; 400: 452-7.
62. Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, Jung J, et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci USA 2000; 97: 6155-60.
63. Levine JD, Lau W, Kwiat G. Leukotrien B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Science 1984; 225: 743-5.
64. Samuelsson B. Mediators of immediate hypersensitivity reactions and inflammation. Science 1983; 220: 568-75.
65. Piomelli D, Volterra A, Dale N, Siegelbaum SA, Kandel ER, Schwartz JH, et al. Lipoxygenase metabolises of arachidonic acid as second messengers for presynaptic inhibition of Aplysia sensory cells. Nature 1987; 328: 38-43.
66. Kim D, Lewis DL, Graziadei L, Neer EJ, Bar-Sagi D, Clapham DE. G-protein βγ-subunits activate the cardiac muscarinic K+-channel via phosphorylase A2. Nature 1989; 337: 557-60.
67. Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, et al. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 2002; 99: 8400-5.
68. Shin J, Cho H, Hwang SW, Jung J, Shin CY, Lee SY, et al. Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci USA 2002; 99: 10150-5.
69. Acs G, Lee J, Marquez VE, Blumberg PM. Distinct structure-activity relations for stimulation of 45Ca uptake and for high affinity binding in cultured rat dorsal root ganglion neurons and dorsal root ganglion membranes. Brain Res Mol Brain Res 1996; 35: 173-82.
70. Szallasi A, Blumberg PM, Annicelli LL, Krause JE, Cortright DN. The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons. Mol Pharmacol 1999; 56: 581-7.
71. Hwang SW, Oh U. Hot channels in airways: pharmacology of the vanilloid receptor. Curr Opin Pharmacol 2002; 2: 235-42
72. Michaelis M, Vogel C. Blenk KH, Arnarson A, Janig W. Inflammatory mediators sensitize acutely axotomized nerve fibers to mechanical stimulation in the rat. J Neurosci 1998; 18: 7581-7.
73. Kumazawa T, Mizumura K, Koda H, Fukusako H. EP receptor subtypes implicated in the PGE2-induced sensitization of polymodal receptors in response to bradykinin and heat. J Neurophysiol 1996; 75: 2361-8.
74. Burgess GM, Mulaney I, McNeill M, Dunn PM, Rang HP. Second messengers involved in the mechanism of action of bradykinin in sensory neurons in culture, J Neurosci 1989; 9: 3314-25.
75. Thayer SA, Perney TM, Miller RJ. Regulation of calcium homeostasis in sensory neurons by bradykinin. J Neurosci 1988; 8: 4089-97.
76. Gammon CM, Allen AC, Morell P. Bradykinin stimulates phosphoinositide hydrolysis and mobilization of arachidonic acid in dorsal root ganglion neurons. J Neurochem 1989; 53: 95-101.
77. Rech PW. Sensory receptors in a mammalian skin-nerve in vitro preparation. Prog Brain Res 1988; 74: 271-76.
78. Steen KH, Steen AE, Reeh PW. A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro. J Neurosci 1995; 15: 3982-3989.
79. Ferreira J, da Silva GL, Calixto JB. Contribution of vanilloid receptors to the overt nociception induced by B2 kinin receptor activation in mice. Br J Pharmacol 2004; 141: 787-94.
80. Magerl W, Westerman RA, Mohner B, Handwerker HO. Properties of transdermal histamine iontophoresis: differential effects of season, gender, and body region. J Invest Dermatol 1990; 94: 347-52.
81. Ward L, Wright E, McMahon SB. A comparison of the effects of noxious and innocuous counterstimuli on experimentally induced itch and pain. Pain 1996; 64: 129-38.
82. Lischetzki G, Rukwied R, Handwerker HO, Schmelz M. Nociceptor activation and protein extravasation induced by inflammatory mediators in human skin. Eur J Pain 2001; 5: 49-57.
83. Koppert W, Martus P, Reeh PW. Interactions of histamine and bradykinin on polymodal C-fibres in isolated rat skin. Eur J Pain 2001; 5: 97-106.
84. Leurs R, Traiffort E, Arrang JM, Tardivel-Lacombe J, Ruat M, Schwartz JC. Guinea pig histamine H1 receptor. II. Stable expression in Chinese hamster ovary cells reveals the interaction with three major signal transduction pathways. J Neurochem 1994; 62: 519-27.
85. 2+ influx via the PLA2/Lipoxygenase/TRPV1 pathway in rat sensory neurons. Neurosci Lett 2004; 361: 159-62.
86. Park H, Park M, Choi J, Choi S, Lee J, Suh Y, et al. Synthesis of 2-substituted-pyrrolidinethiourea derivatives and their antagonist effect on vanilloid receptor. Bioorg Med Chem Lett 2003; 13: 197-200.
87. Park HG, Park MK, Choi JY, Choi SH, Lee J, Park BS, et al. Synthesis of N, N′, N″-trisubstituted thiourea derivatives and their antagonist effect on the vanilloid receptor. Bioorg Med Chem Lett 2003; 13: 601-4.
88. Yoon J, Choi H, Lee HJ, Ryu CH, Park HG, Sun YG, et al. Chain-branched acyclic phenethylthiocarbamates as vanilloid receptor antagonists. Bioorg Med Chem Lett 2003; 13: 1549-52.
89. Lee J, Kang M, Shin M, Kim JM, Kang SU, Lim JO, et al. N-(3-acyloxy-2-benzylpropyl)-N′-4-(methylsulfonylamino)benzyl] thio-urea analogues: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor. J Med Chem 2003; 46: 3116-26.
90. Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 1999; 51: 159-212.
91. Kress M, Zeilhofer HU. Capsaicin, protons and heat: new excitement about nociceptors. Trends Pharmacol Sci 1999; 20: 112-18.
92. Planells-Cases R, Aracil A, Merino JM, Gallar J, Perez-Paya E, Belmonte C, et al. Arginine-rich peptides are blockers of VR-1 channels with analgesic activity. FEBS Lett 2000; 481: 131-6.
93. Wahl P, Foged C, Tullin S, Thomsen C. Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist. Mol Pharmacol 2001; 59: 9-15.
94. Loth A, Blumberg PM, Chen Z, Kozikowski AP. Design of a high-affinity competitive antagonist of the vanilloid receptor selective for the calcium entry-linked receptor population. Mol Pharmacol 2004; 65: 282-91.
95. Lee J, Kang SU, Lim JO, Choi HK, Jin M, Toth A, et al. N-[4-(Methylsulfonylamino)benzyl]thiourea analogues as vanilloid receptor antagonists: analysis of structure-activity relationships for the 'C-Region'. Bioorg Med Chem 2004; 12: 371-85.
96. Gunthorpe MJ, Rami HK, Jerman JC, Smart D, Gill CH, Soffin EM, et al. Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist. Neuropharmacology 2004; 46: 133-49.
97. Wang Y, Szabo T, Welter JD, Toth A, Tran R, Lee J, et al. High Affinity Antagonists of the Vanilloid Receptor. Mol Pharmacol 2003; 63: 958.
98. Wang Y, Szabo T, Welter JD, Toth A, Tran R, Lee J, et al. High affinity antagonists of the vanilloid receptor. Mol Pharmacol 2002; 62: 947-56.
99. Santos AR, Calixto JB. Ruthenium red and capsazepine antinociceptive effect in formalin and capsaicin models of pain in mice. Neurosci Lett 1997; 235: 73-6.
100. Woods AJ, Stock MJ, Gupta AN, Wong TT, Andrews PL. Thermoregulatory effects of resiniferatoxin in the rat. Eur J Pharmacol 1994; 264: 125-33.
101. DeHaven-Hudkins DL, Dolle RE. Peripherally restricted opioid agonists as novel analgesic agents. Curr Pharm Design 2004;10(7): 743-57.
102. Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE, Nicolaides DN. Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities. Curr Pharm Design 2004; 10(30): 3813-33.
103. McCleane G. Cholecystokinin antagonists a new way to improve the analgesia from old analgesics? Curr Pharm Design 2004; 10(3): 303-14.